Development and validation of nomogram models for predicting urinary incontinence following radical prostatectomy in high-risk prostate cancer patients.

IF 2.9 3区 医学 Q2 ONCOLOGY
American journal of cancer research Pub Date : 2025-07-15 eCollection Date: 2025-01-01 DOI:10.62347/ZYAA3728
Kaiqiang Chen, Weihua Liu, Jian Wu, Renqiang He, Shanghuan Xie, Yaowu Su
{"title":"Development and validation of nomogram models for predicting urinary incontinence following radical prostatectomy in high-risk prostate cancer patients.","authors":"Kaiqiang Chen, Weihua Liu, Jian Wu, Renqiang He, Shanghuan Xie, Yaowu Su","doi":"10.62347/ZYAA3728","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To develop a risk stratification model for predicting urinary incontinence following radical prostatectomy (RP) in high-risk prostate cancer patients based on their clinicopathological characteristics.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 520 prostate cancer patients who underwent RP between January 2016 and January 2024. Baseline characteristics, pathological data, laboratory parameters, and surgery-related factors were collected. Urinary continence status at 1, 3, and 6 months postoperatively was assessed. Multivariate logistic regression analyses were performed to identify independent risk factors, and nomograms were constructed to predict urinary incontinence risk at each time point.</p><p><strong>Results: </strong>Urinary incontinence rates at 1, 3, and 6 months postoperatively were 92.88%, 69.62%, and 23.65%, respectively. At 1 month, a higher Gleason score (OR=2.178, P=0.003) was a risk factor, while robot-assisted surgery was protective (OR=0.289, P=0.003). At 3 months, higher Gleason score (OR=1.565, P=0.004) increased risk, whereas lower BMI (<25 kg/m<sup>2</sup>) (OR=0.448, P=0.005) and longer preoperative membranous urethral length (≥14 mm) (OR=2.368, P<0.001) were protective. At 6 months, shorter membranous urethral length (<14 mm) (OR=3.622, P<0.001), neoadjuvant hormone therapy (OR=5.783, P<0.001), and higher Gleason score (OR=2.824, P<0.001) were risk factors, while lower BMI (OR=0.317, P<0.001), smaller prostate volume (<40 mL) (OR=0.591, P=0.044), and lower CONUT score (<4) (OR=0.372, P<0.001) were protective. The nomograms showed good predictive performance, with AUCs of 0.679 at 3 months and 0.818 at 6 months.</p><p><strong>Conclusions: </strong>The developed nomograms effectively stratify the risk of urinary incontinence following RP in high-risk patients, facilitating individualized perioperative management and rehabilitation strategies.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"15 7","pages":"3017-3034"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344162/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/ZYAA3728","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To develop a risk stratification model for predicting urinary incontinence following radical prostatectomy (RP) in high-risk prostate cancer patients based on their clinicopathological characteristics.

Methods: A retrospective analysis was conducted on 520 prostate cancer patients who underwent RP between January 2016 and January 2024. Baseline characteristics, pathological data, laboratory parameters, and surgery-related factors were collected. Urinary continence status at 1, 3, and 6 months postoperatively was assessed. Multivariate logistic regression analyses were performed to identify independent risk factors, and nomograms were constructed to predict urinary incontinence risk at each time point.

Results: Urinary incontinence rates at 1, 3, and 6 months postoperatively were 92.88%, 69.62%, and 23.65%, respectively. At 1 month, a higher Gleason score (OR=2.178, P=0.003) was a risk factor, while robot-assisted surgery was protective (OR=0.289, P=0.003). At 3 months, higher Gleason score (OR=1.565, P=0.004) increased risk, whereas lower BMI (<25 kg/m2) (OR=0.448, P=0.005) and longer preoperative membranous urethral length (≥14 mm) (OR=2.368, P<0.001) were protective. At 6 months, shorter membranous urethral length (<14 mm) (OR=3.622, P<0.001), neoadjuvant hormone therapy (OR=5.783, P<0.001), and higher Gleason score (OR=2.824, P<0.001) were risk factors, while lower BMI (OR=0.317, P<0.001), smaller prostate volume (<40 mL) (OR=0.591, P=0.044), and lower CONUT score (<4) (OR=0.372, P<0.001) were protective. The nomograms showed good predictive performance, with AUCs of 0.679 at 3 months and 0.818 at 6 months.

Conclusions: The developed nomograms effectively stratify the risk of urinary incontinence following RP in high-risk patients, facilitating individualized perioperative management and rehabilitation strategies.

预测高危前列腺癌患者根治性前列腺切除术后尿失禁的nomogram模型的建立与验证。
目的:建立基于临床病理特征的高危前列腺癌根治性前列腺切除术(RP)后尿失禁风险分层模型。方法:回顾性分析2016年1月至2024年1月期间接受RP治疗的520例前列腺癌患者。收集基线特征、病理数据、实验室参数和手术相关因素。评估术后1、3、6个月的尿失禁情况。多因素logistic回归分析确定独立危险因素,并构建nomogram预测各时间点尿失禁风险。结果:术后1、3、6个月尿失禁率分别为92.88%、69.62%、23.65%。1个月时,较高的Gleason评分(OR=2.178, P=0.003)是危险因素,而机器人辅助手术是保护因素(OR=0.289, P=0.003)。在3个月时,较高的Gleason评分(OR=1.565, P=0.004)增加了风险,而较低的BMI (2) (OR=0.448, P=0.005)和较长的术前膜性尿道长度(≥14 mm) (OR=2.368, P)增加了风险。结论:开发的nomogram尿路图有效地分层了高危患者RP术后尿失禁的风险,促进了个体化围手术期管理和康复策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
3.80%
发文量
263
期刊介绍: The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信